Duke, UNC-Chapel Hill scientists identify new antibody for COVID-19 and variants
November 2, 2021 A research collaboration between scientists at Duke University and the University of North Carolina at Chapel Hill has identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-19 as well as the original SARS illness.
NC prisons study finds better, safer outcomes with diversion program for mental, behavioral health
October 29, 2021 Researchers found that people experiencing incarceration in North Carolina who were assigned to a therapeutic diversion unit instead of restrictive housing were at least three times less likely to commit further infractions, harm themselves or require inpatient mental health treatment.
Financial incentives for COVID-19 vaccination are effective, finds evaluation of NC program by NCDHHS, NCCU and UNC-Chapel Hill
October 25, 2021 The $25 Summer Card pilot program operated by North Carolina Department of Health and Human Services (NCDHHS) was successful in encouraging COVID-19 vaccination, according to a published research letter by authors from NCDHHS, North Carolina Central University and the UNC-Chapel Hill Gillings School of Global Public Health.
Cline named interim director of NC Institute for Public Health
October 15, 2021 Steve Cline, DDS, MPH, will act as interim director of the North Carolina Institute for Public Health, effective October 1.
Multiple-drug involvement in overdose deaths has risen in NC
October 14, 2021 Between 2015 and 2019, North Carolina saw an increase in overdose deaths that involved multiple drugs, highlighting the rapidly changing nature of drug overdoses in the state.
Dr. Ralph Baric receives O. Max Gardner Award for coronavirus research
October 12, 2021 UNC-Chapel Hill professor Dr. Ralph Baric — a world renowned coronavirus expert — has contributed to the development of life-saving vaccines and pharmaceutical treatments during the COVID-19 pandemic.
Carolina research produces effective experimental pill to treat COVID-19
October 1, 2021 University of North Carolina at Chapel Hill research set the stage to seek emergency authorization of the first oral antiviral drug to treat COVID-19.
Reducing "tobacco swamps" could improve public health
September 30, 2021 Reducing “tobacco swamps” — densely located stores that sell tobacco products — could have a major impact on public health, according to new research.
Blue Cross NC, UNC join forces for new clinical study to improve food security, chronic health conditions
September 22, 2021 With a $3.2-million investment, Blue Cross NC is collaborating with UNC Health and UNC-Chapel Hill researchers to conduct a first-of-its-kind clinical study to establish sustainable best practices for helping individuals put nutritious food options on the table and improve health.
Samuel-Ryals honored with prestigious Hettleman award
September 10, 2021 Dr. Cleo Samuel-Ryals, associate professor of health policy and management at the Gillings School, is one of four faculty members who have been awarded the 2021 Phillip and Ruth Hettleman Prizes for Artistic and Scholarly Achievement.
